BioTime, Inc. (NYSE American and TASE: BTX)…today announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, Inc., effective August 12, 2019… The Company’s new identity reflects its commitment to becoming an innovative, leading cell therapy company and highlights its extensive cell therapy platform.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”